Literature DB >> 30661504

Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.

Kristin P Guilliams1,2, Melanie E Fields2, Michael M Dowling3.   

Abstract

Entities:  

Keywords:  anemia; cerebrovascular circulation; hemolysis; hydroxyurea; oxygen consumption; stroke

Mesh：

Substances：

Year:  2019        PMID： 30661504      PMCID： PMC6385587          DOI： 10.1161/STROKEAHA.118.020482

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  91 in total

1.  Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.

Authors:  IkeOluwa Lagunju; Biobele J Brown; Olugbemiro Sodeinde
Journal:  Pediatr Blood Cancer       Date:  2015-04-01       Impact factor: 3.167

2.  Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.

Authors:  S T Miller; E A Macklin; C H Pegelow; T R Kinney; L A Sleeper; J A Bello; L D DeWitt; D M Gallagher; L Guarini; F G Moser; K Ohene-Frempong; N Sanchez; E P Vichinsky; W C Wang; D L Wethers; D P Younkin; R A Zimmerman; M R DeBaun
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

3.  Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.

Authors:  Michael M Dowling; Charles T Quinn; Claudio Ramaciotti; Julie Kanter; Ifeyinwa Osunkwo; Baba Inusa; Rathi Iyer; Janet L Kwiatkowski; Clarissa Johnson; Melissa Rhodes; William Owen; John J Strouse; Julie A Panepinto; Lynne Neumayr; Sharada Sarnaik; Patricia A Plumb; Nomazulu Dlamini; Fenella Kirkham; Linda S Hynan
Journal:  Br J Haematol       Date:  2016-10-21       Impact factor: 6.998

4.  Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.

Authors:  Wuyang Yang; Risheng Xu; Jose L Porras; Clifford M Takemoto; Syed Khalid; Tomas Garzon-Muvdi; Justin M Caplan; Geoffrey P Colby; Alexander L Coon; Rafael J Tamargo; Judy Huang; Edward S Ahn
Journal:  J Neurosurg Pediatr       Date:  2017-07-07       Impact factor: 2.375

5.  Sickle cell anemia and central nervous system infarction: a neuropathological study.

Authors:  S M Rothman; K H Fulling; J S Nelson
Journal:  Ann Neurol       Date:  1986-12       Impact factor: 10.422

6.  Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans.

Authors:  W J Powers; R L Grubb; D Darriet; M E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

Review 7.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

8.  Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.

Authors:  Mathula Thangarajh; Genyan Yang; Dana Fuchs; Maria R Ponisio; Robert C McKinstry; Alok Jaju; Michael J Noetzel; James F Casella; Emily Barron-Casella; W Craig Hooper; Sheree L Boulet; Christopher J Bean; Meredith E Pyle; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Bruce A Vendt; Mark Rodeghier; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-09-07       Impact factor: 6.998

9.  Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.

Authors:  C H Pegelow; R J Adams; V McKie; M Abboud; B Berman; S T Miller; N Olivieri; E Vichinsky; W Wang; D Brambilla
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406

10.  Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.

Authors:  Frédéric B Piel; Anand P Patil; Rosalind E Howes; Oscar A Nyangiri; Peter W Gething; Mewahyu Dewi; William H Temperley; Thomas N Williams; David J Weatherall; Simon I Hay
Journal:  Lancet       Date:  2012-10-25       Impact factor: 79.321
View more
  10 in total

1.  A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.

Authors:  Shuai Yuan; Lori C Jordan; Larry T Davis; Petrice M Cogswell; Chelsea A Lee; Niral J Patel; Spencer L Waddle; Meher Juttukonda; R Sky Jones; Allison Griffin; Manus J Donahue
Journal:  Br J Haematol       Date:  2020-12-16       Impact factor: 6.998

2.  Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample.

Authors:  Richard Idro; Amelia K Boehme; Michael Kawooya; Samson K Lubowa; Deogratias Munube; Paul Bangirana; Robert Opoka; Ezekiel Mupere; Angela Lignelli; Philip Kasirye; Nancy S Green; Frank J Minja
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-02-11       Impact factor: 2.136

3.  Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study.

Authors:  Julie Gargot; Marie-Claire Parriault; Antoine Adenis; Jérôme Clouzeau; Kim-Anh Dinh Van; Balthazar Ntab; Antoine Defo; Mathieu Nacher; Narcisse Elenga
Journal:  Front Med (Lausanne)       Date:  2022-06-28

4.  Choroid plexus perfusion in sickle cell disease and moyamoya vasculopathy: Implications for glymphatic flow.

Authors:  Skylar E Johnson; Colin D McKnight; Lori C Jordan; Daniel O Claassen; Spencer Waddle; Chelsea Lee; Maria Garza; Niral J Patel; L Taylor Davis; Sumit Pruthi; Paula Trujillo; Rohan Chitale; Matthew Fusco; Manus J Donahue
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-28       Impact factor: 6.200

5.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

Review 6.  Stroke and presence of patent foramen ovale in sickle cell disease.

Authors:  Constantina Aggeli; Kali Polytarchou; Yannis Dimitroglou; Dimitrios Patsourakos; Sophia Delicou; Sophia Vassilopoulou; Eleftherios Tsiamis; Kostas Tsioufis
Journal:  J Thromb Thrombolysis       Date:  2021-02-26       Impact factor: 2.300

7.  Cerebrovascular manifestations in hematological diseases: an update.

Authors:  José M Ferro; Joana Infante
Journal:  J Neurol       Date:  2021-02-13       Impact factor: 4.849

8.  Association of laboratory markers and cerebral blood flow among sickle cell anemia children.

Authors:  Corynne Stéphanie Ahouéfa Adanho; Sètondji Cocou Modeste Alexandre Yahouédéhou; Sânzio Silva Santana; Camilo Vieira; Rayra Pereira Santiago; Jeanne Machado de Santana; Thassila Nogueira Pitanga; Milena Magalhães Aleluia; Vítor Valério Maffili; Ivana Paula Ribeiro Leite; Dalila Luciola Zanette; Isa Menezes Lyra; Marilda Souza Goncalves
Journal:  Front Pediatr       Date:  2022-08-26       Impact factor: 3.569

Review 9.  Pediatric Stroke: Overview and Recent Updates.

Authors:  Mary Hollist; Katherine Au; Larry Morgan; Padmashri A Shetty; Riddhi Rane; Abraham Hollist; Angela Amaniampong; Batool F Kirmani
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

10.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.